DELAYED CEREBRAL THROMBOSIS AFTER INITIAL GOOD RECOVERY FROM PNEUMOCOCCAL MENINGITIS
PAST AS PROLOGUE: DELAYED STROKE AS A PARAINFECTIOUS PROCESS OF BACTERIAL MENINGITIS?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Schut et al.1 reported 6 patients who had ischemic stroke 7–30 days after initially good recovery from pneumococcal meningitis (PM). All patients were treated with adjunctive corticosteroids. Based on autopsy findings in 2 patients, Schut et al. proposed that stroke is caused by delayed cerebral thrombosis—not by vasculitis—and possibly related to adjunctive corticosteroid therapy.
Stroke is a well-known complication of PM, but the definite timing of stroke onset and its association with initial therapy are unknown.2 We reanalyzed data of 17 previously published patients with ischemic stroke complicating PM3 focusing on timing of stroke onset, initial corticosteroid therapy, and causes of stroke.
Median onset of stroke was 4 (0–50) days after initiation of therapy. In 5 cases, stroke occurred 6–10 days after initiation of antibiotic therapy and in another 5 cases after more than 10 days. CSF parameters had initially improved in all 10 patients with stroke occurring at least 6 days after therapy was started. However, most of them were severely affected. Seven out of 10 were still comatose or sedated and only 3 out of 10 were following commands at stroke onset. Signs of narrowing of cerebral arteries were detected in 8 out of 10 patients (2 of them receiving corticosteroids) by conventional angiography,5 …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Early lacunar strokes complicating polyarteritis nodosaThrombotic microangiopathyMarc D. Reichhart, Julien Bogousslavsky, Robert C. Janzer et al.Neurology, February 22, 2000 -
Articles
Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery diseaseR. Kern, W. Steinke, M. Daffertshofer et al.Neurology, September 26, 2005 -
Articles
Ultrasound findings in carotid artery dissectionAnalysis of 43 PatientsMatthias Sturzenegger, Heinrich P. Mattle, Anita Rivoir et al.Neurology, April 01, 1995 -
Articles
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) TrialE. Feldmann, J. L. Wilterdink, A. Kosinski et al.Neurology, April 04, 2007